Selection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: A systematic review and meta-analysis

BACKGROUND: The use of hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery has been extensively studied in patients with peritoneal carcinomatosis from various malignancies. However, the effectiveness of HIPEC for ovarian cancer is still controversial. Therefore, we perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Se Ik, Cho, Jaehyun, Lee, Eun Ji, Park, Sunwoo, Park, Soo Jin, Seol, Aeran, Lee, Nara, Yim, Ga Won, Lee, Maria, Lim, Whasun, Song, Gwonhwa, Chang, Suk Joon, Kim, Jae Won, Kim, Hee Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922570/
https://www.ncbi.nlm.nih.gov/pubmed/31852138
http://dx.doi.org/10.1097/MD.0000000000018355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922570/
https://www.ncbi.nlm.nih.gov/pubmed/31852138
http://dx.doi.org/10.1097/MD.0000000000018355

Ejemplares similares